{"id":93359,"date":"2024-05-07T12:43:00","date_gmt":"2024-05-07T15:43:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/philips-shareholders-approve-all-proposals-at-the-agm-2024\/"},"modified":"2024-05-07T12:43:00","modified_gmt":"2024-05-07T15:43:00","slug":"philips-shareholders-approve-all-proposals-at-the-agm-2024","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/philips-shareholders-approve-all-proposals-at-the-agm-2024\/","title":{"rendered":"Philips shareholders approve all proposals at the AGM 2024"},"content":{"rendered":"<p><b>Royal Philips<\/b><\/p>\n<p>May 7, 2024<\/p>\n<p><b>Amsterdam, the Netherlands  <\/b><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mSV4H9ujk7SIG3bAaZS0ytuUYRKLyWOdookc_yNnwnH7pnfwUu7ZIvUpN6w4ZAGtgyrjkI0yUC-zzdiWG6rGHPlrx4M0sNRprwY-2Xfn7sk=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Royal Philips<\/u><\/a> (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including:<\/p>\n<ul>\n<li>The re-appointment of Chairman Feike Sijbesma and Peter L\u00f6scher as members of the Supervisory Board.<\/li>\n<li>The appointment of Beno\u00eet Ribadeau-Dumas as member of the Supervisory Board.<\/li>\n<li>The appointment of Charlotte Hanneman as member of the Board of Management, with effect from October 1, 2024.<\/li>\n<li>The discharge of the members of the Board of Management and members of the Supervisory Board.<\/li>\n<li>A full overview of the resolutions taken at the AGM 2024 can be found below.<\/li>\n<\/ul>\n<p>Feike Sijbesma, Chairman of Philips Supervisory Board, said: I am very pleased with the re-appointment of Peter and the appointment of Beno\u00eet, who has extensive experience with large and global industrial companies. With our highly knowledgeable and experienced members, the composition of our Supervisory Board is very strong and well positioned to fulfill our vital duty of advising, challenging, and supporting Management in executing Philips strategy, and it is an honor to serve a second term leading this Board.<\/p>\n<p>I would also like to welcome Charlotte to Philips. She will join Philips Board of Management on October 1, and fulfill the role of Chief Financial Officer.\u00a0Her strong MedTech knowledge and extensive finance experience, coupled with her energy and passion for the healthcare industry, make her an ideal fit for the role. Charlotte will work with Abhijit, Philips current Chief Financial Officer, until October, ensuring a smooth transition. I would also like to thank Abhijit in advance for his tremendous contribution to Philips over the last 38 years, and more particularly during his nine years as Chief Financial Officer.<\/p>\n<p>Roy Jakobs, CEO of Royal Philips said: I want to congratulate our Chairman Feike with his re-appointment. Together with Peter and Beno\u00eet, as well as the other Supervisory Board members, they represent the best in the industry to provide oversight and valuable insights to Management in executing Philips 2023-2025 plan to create value with sustainable impact for all stakeholders. We look forward to a continued strong and successful collaboration, as we aim to improve the health and well-being of people through meaningful innovation.<\/p>\n<p><b>All resolutions taken at the AGM 2024:<\/b><\/p>\n<table style=\"border-collapse: collapse;width:453.35pt;border-collapse:collapse\">\n<tr>\n<td style=\"width:84.74px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>Agenda item<\/b>  <\/td>\n<td style=\"width:519.74px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Resolution<\/b>  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>2<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Annual Report 2023<\/b> <\/p>\n<ul>\n<li>Adoption of the financial statements 2023<\/li>\n<li>Adoption of a dividend of EUR 0.85 per common share, in common shares, against retained earnings<\/li>\n<li>Positive advisory vote on the approval of the Remuneration Report 2023<\/li>\n<li>Discharge of the members of the Board of Management<\/li>\n<li>Discharge of the members of the Supervisory Board<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>3<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Composition of the Board of Management <\/b> <\/p>\n<ul>\n<li>Appointment of Ms Hanneman as member of the Board of Management with effect from October 1, 2024<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>4<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Composition of the Supervisory Board\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/b> <\/p>\n<ul>\n<li>Re-appointment of Mr Sijbesma as member of the Supervisory Board with effect from May 7, 2024<\/li>\n<li>Re-appointment Mr L\u00f6scher as member of the Supervisory Board with effect from May 7, 2024<\/li>\n<li>Appointment of Mr Ribadeau-Dumas as member of the Supervisory Board with effect from May 7, 2024<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>5<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Remuneration of the Board of Management and the Supervisory Board<\/b> <\/p>\n<ul>\n<li>Adoption of Remuneration Policy for the Board of Management <\/li>\n<li>Adoption of Remuneration Policy for the Supervisory Board<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>6<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Authorization of the Board of Management to issue shares or grant rights to acquire shares and restrict or exclude pre-emption rights<\/b>  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>7<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Authorization of the Board of Management to acquire shares in the company<\/b>  <\/td>\n<\/tr>\n<tr>\n<td style=\"width:84.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">  <b>8<\/b>  <\/td>\n<td style=\"width:519.74px;border-right: solid black 1pt;border-bottom: solid black 1pt;vertical-align: top\">  <b>Cancellation of shares<\/b>  <\/td>\n<\/tr>\n<\/table>\n<p>Further details about the dividend can be found via this\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EpoIPkP4eRueUFoGoQbduuVquzITLNycHeBwGm1QlL3M5PpfzFLhuP38uIaGLtNGboaHiaWLSZc4gVjICpb6Wrc8or-I6paF7SlDDH1jJGLx5XJsBHX0MJrMpU6MHQ2U\" rel=\"nofollow noopener\" target=\"_blank\"><u>link<\/u><\/a>, and additional information on the composition of the Board of Management, the Executive Committee and the Supervisory Board can be found\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r9_xuTxailycr9pN0Oq6dr2EEQ2p7WV4NpXyYmn4PCiURB2nSJZDTlrlYKYZwltMUzFzFenUl2XDwsJI_qdg4zq3i8rJmHHwxT7Be-CHC3U8lqyx7s8xk_rcTE9HmhFT\" rel=\"nofollow noopener\" target=\"_blank\"><u>here<\/u><\/a>. Philips 2023 financial statements are included in its Annual Report 2023 that was <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KTXYiNjBvQkMLVR9MSE92qrcv73kBJB0jL9aNQoPwt1nloW-1CEOLC_2_ooPy9K71IpTFazOvrs-lfcyLa94GN8o2KIzV8V1GBDWptXu8Wqg6h3klkNIpImDyN120yaQ\" rel=\"nofollow noopener\" target=\"_blank\"><u>published<\/u><\/a> on February 20, 2024.<\/p>\n<p> For more information about Philips AGM 2024, please click on this\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EpoIPkP4eRueUFoGoQbduhTRLG5bIQsuzm67NaguxWd-jZ6xNmojZI3kiVJaBhb-9fqYfJ2hscAOV0DizPiPHA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>link<\/u><\/a>.<\/p>\n<p align=\"left\"><b>For further information, please contact:<\/b><\/p>\n<p>Elco van Groningen<br \/>Philips External Relations<br \/>Tel.: +31 6 8103 9584<br \/>E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QlJRMDK6qCPS5k74dOfn_2p3WWitDEvtznv3irwNL9q17AoxLo48sn-TbusdgZNfYLtS7QIjLEf00FSEnbt2om5CNAdwaOT_pat8HckQZxNzPVuwIIXABZspaqTYdQdS\" rel=\"nofollow noopener\" target=\"_blank\"><u>elco.van.groningen@philips.com<\/u><\/a><\/p>\n<p>Dorin Danu<br \/>Philips Investor Relations<br \/>Tel.: +31 20 59 77055<br \/>E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VfCSbq832IW-HOLSEcV4ECVl9h2AIZyUl6CMX31v_aEiCU3H5tHkCoV87qcRuuanc_WSHKnVn6ph30Q5-FIPROsVEL3tDtLpdoP0d26-DKg=\" rel=\"nofollow noopener\" target=\"_blank\"><u>dorin.danu@philips.com<\/u><\/a><\/p>\n<p><b>About Royal Philips<\/b><br \/>Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people&#8217;s health and well-being through meaningful innovation. Philips patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TKpHEu8oaZDq_frMexkENXBm144vSG_8ylnYLPBQwhwQ6XwfGdHu4OQRUe0YxUQ8AqjuTFRB9Xwdi0z1ZXjA9C7frxSalsFvX-l18JKJIh5uRgAHvjmggrjMu18zN6fI\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.philips.com\/newscenter<\/u><\/a>.<\/p>\n<p id=\"gnw_attachments_section-header\">\n <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n  <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/f2d5468d-d3f3-456b-b62e-aeb365b8b83e\" rel=\"noopener\">Philips AGM 2024<\/a>\n<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDk0OTUxNyM0MDE4NDE2OTYjMjAwMjgwMg==\" \/> <br \/><img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NTU5OTEzMGItYmNhMy00YTAxLWE4OTMtNGNmYWRlNGQ2MTc3LTEwMTQzNzU=\/tiny\/Philips-International-B-V-.png\" \/><br \/>\n<a href=\"https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/e5826782-01bc-45e7-b448-9ca1eae0125e\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/e5826782-01bc-45e7-b448-9ca1eae0125e\/small\/philips-logo-logotype-emblem-700x128-png.png\" border=\"0\" width=\"150\" height=\"27\" alt=\"Primary Logo\" \/><\/a><\/p>\n<p>A <b>OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da <b>OESP<\/b> e sao de inteira responsabilidade da <b>GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"May 7, 2024\nAmsterdam, the Netherlands  Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-93359","post","type-post","status-publish","format-standard","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/93359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=93359"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/93359\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=93359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=93359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=93359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}